
Epirubicin Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 10 mg/5 mL, 50 mg/25 mL, 200 mg/100 mL
Reference Brands: Ellence®(US); Farmorubicin®(EU)
Category: Oncology Cancer Care
Epirubicin is available in Injection and strengths such as 10 mg/5 mL, 50 mg/25 mL, 200 mg/100 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Epirubicin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Epirubicin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Epirubicin Hydrochloride is a widely used oncology injectable in the US and EU, primarily indicated for breast cancer, gastric cancer, and bladder cancer. It is a potent anthracycline chemotherapy agent that interferes with DNA replication, leading to cancer cell death. Available in concentrations like 2 mg/mL across multiple vial sizes, Epirubicin offers versatility for intravenous and intravesical administration. Approved under several brands, including Farmorubicin®, it is a key component in combination regimens. Pharmaceutical B2B buyers and distributors in the EU and US recognize Epirubicin as a high-demand, regulated oncology product with broad market application.
Frequently Asked Questions
Related Products
Atezolizumab
Strength:
1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength:
120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers